Supporting Latino Youth with Type 1 Diabetes in Using the Medtronic MiniMed 780G Insulin Pump Through a Spanish-Language Support Program
Led by University of Colorado, Denver · Updated on 2026-10-30
15
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate whether a support program delivered in Spanish or both English and Spanish can help Latino youth with Type 1 Diabetes better use the Medtronic MiniMed 780G system. The study focuses on a linguistically and culturally tailored onboarding model for this automated insulin delivery system to see if it improves technology adoption and health outcomes for this population. Participants are LatinoHispanic youth aged 10 to 20 who manage their diabetes and are willing to use this system.
Participants will use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months. They will receive a culturally tailored onboarding and support program, including one-on-one nutrition support with a Registered Dietitian, a pump start class conducted in Spanish or both English and Spanish for bilingual participants by a Certified Diabetes Educator, and regular virtual check-ins with native Spanish-speaking study team members. The device includes a Spanish-language menu and user interface to enhance accessibility.
Throughout the study, participants will attend one in-person nutrition and pump start class and engage in ongoing virtual check-ins. Researchers will measure how many participants continue using the system at 6 months as the primary outcome. Secondary outcomes include changes in blood sugar control HbA1c, time spent in target glucose range, and satisfaction and confidence in managing diabetes technology for both participants and their caregivers. The study will last up to 8 months with continuous monitoring and support.
CONDITIONS
Brief Title
Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative
Research Team
S
Study Coordinator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Barbara Davis Center of Childhood Diabetes, University of Co
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Investigational Onboarding Program
Standard Onboarding Support
What it is
An eight‑month, culturally and linguistically tailored onboarding and support program delivered in Spanish or bilingual format alongside the Medtronic MiniMed 780G Automated Insulin Delivery system for Latino/Hispanic youth with type 1 diabetes
The typical practice involves standard insulin pump start‑up training conducted in the clinician’s language without cultural tailoring, following manufacturer and clinic protocols
Role in the trial
Participants receive the tailored onboarding intervention and the MiniMed 780G system as part of routine management for up to eight months
Not a trial arm; represents usual care outside of study settings
Primary use
To promote initiation and sustained use of the Medtronic MiniMed 780G system in Spanish‑speaking youth
Teach pump operation and support technology use for safe and effective glycemic management in youth
How it is given or performed
One‑on‑one nutrition support with a Registered Dietitian, a pump start class in Spanish or bilingual format by a Certified Diabetes Educator, plus virtual check‑ins with study staff
Standard class or training session often without dedicated bilingual educators, followed by routine clinic follow‑up
Evidence status
Evidence is pending; trial will measure continuation of use at six months and clinical metrics through eight months
Education and support practices are broadly accepted and guideline‑recommended but lack specific evidence for culturally tailored Spanish‑language approach
Important risks
Potential risks align with pump and AID system use (e.g. infusion set issues, device alarms), but no additional risks from the education program are specified
Routine pump initiation carries similar device‑related risks inherent to approved insulin delivery systems
Important limitations
Single‑group design without control group limits causal interpretation; specific to Latino/Hispanic youth aged 10‑20, which may limit broader generalizability
Standard practices may not reach Spanish‑speaking or culturally diverse populations effectively without adaptation
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 10Years - 20Years
All Genders
Eligibility Criteria
You may qualify if you...
Age 10 to 20 years old
Diagnosis of type 1 diabetes
Self-identify as Latino or Hispanic
Currently managing diabetes with any regimen including multiple daily injections or non-Medtronic insulin delivery systems
Willing to transition to and use the Medtronic MiniMed 780G system for the study duration
You will not qualify if you...
Current use of any Medtronic diabetes technology
More than one episode of diabetic ketoacidosis within 12 months before enrollment
Current pregnancy
Any significant medical condition that may interfere with participation or data interpretation
Inability or unwillingness to use the Medtronic MiniMed 780G system throughout the study
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Treatment
Duration - 8 months
Participants receive the Medtronic MiniMed 780G insulin pump and participate in a culturally tailored onboarding and support program including one-on-one nutrition support, a pump start class, and regular virtual check-ins.
One in-person class and regular virtual check-ins
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
AHEAD Program to Improve Diabetes Management in Emerging Adults with Type 1 Diabetes During Transition to Adult Care
Evaluating a Tele-diabetes Remote Monitoring System Using WhatsApp Alerts to Improve Blood Sugar Control and Quality of Life in Children and Youth With Type 1 Diabetes
Assessing the Safety and Accuracy of the RIGHTEST iFree 2 Continuous Glucose Monitoring System in Pregnant Women with Diabetes Mellitus
Supporting Latino Youth with Type 1 Diabetes in Using the Medtronic MiniMed 780G Insulin Pump Through a Spanish-Language Support Program
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Tomando Control: a culturally appropriate diabetes education program for Spanish-speaking individuals with type 2 diabetes mellitus--evaluation of a pilot project.
Maria Mauldon, Gail D'Eramo Melkus, Mayra Cagganello
Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: assessment of improvements in treatment satisfaction with a new insulin analogue.
The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ.
Clare Bradley, Rosalind Plowright, John Stewart...